Hair Repigmentation During Cerebrolysin Therapy

Summary

Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes of follicular repigmentation that occurs during the Cerebrolysin treatment.

Timeline

Start

2014-06-02

Primary completion

2015-12-07

Completion

2016-12-23

Drugs

Indications